Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    Rh incompatibility
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With Hyperbilirubinemia
Conditions: Jaundice, Neonatal;   Hyperbilirubinemia, Neonatal
Interventions: Drug: stannsoporfin;   Drug: Placebo
2 Completed Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
Conditions: Hyperbilirubinemia;   Erythroblastosis, Fetal
Interventions: Drug: Intravenous Immunoglobulin;   Drug: Normal saline solution
3 Completed Doppler or Amniocentesis to Predict Fetal Anemia
Condition: Rh Isoimmunization
Intervention: Procedure: Fetal Middle Cerebral Artery Doppler measurement

Indicates status has not been verified in more than two years